Neoprene (Polychloroprene) Surgical Glove Market Size, Share, Opportunities, And Trends By End-User (Hospitals And Clinics, Ambulatory Surgical Centers, Others), And By Geography - Forecasts From 2025 To 2030

The neoprene (polychloroprene) surgical glove market is estimated at US$460.300 million in 2025, growing at a CAGR of 5.00% to reach the market size of US$598.712 million by 2030.

Neoprene surgical gloves are a type of medical glove made from neoprene, a synthetic rubber. They are known for their chemical resistance, flexibility, and durability, making them suitable for various medical and surgical applications. Neoprene gloves are allergen-free, providing comfort and tactile sensitivity, effective barrier protection, and durability. The demand for neoprene gloves is directly tied to the number of medical procedures and surgeries performed, as well as the increasing prevalence of cancer and chemotherapy treatments. Regulatory compliance ensures the quality, safety, and efficacy of neoprene gloves in the healthcare market.

These gloves are capable of maintaining flexibility at high-temperature ranges and also exhibit elevated chemical stability. Their use in the healthcare industry is also considered safer, as they offer extra protection to healthcare professionals and patients by reducing the risk of allergic reactions caused by chemical accelerators and latex. Thus, the rising incidence of latex allergy among healthcare professionals is significantly driving the demand for neoprene surgical gloves.

The market growth is majorly attributed to the growing adoption of these gloves across the healthcare industry, as they are risk-free of allergic reactions and offer more resistance and strength in comparison to latex gloves. Neoprene is one of the types of synthetic materials which are produced by the polymerization of chloroprene. The strength and resistance offered by these gloves, which is comparatively high as compared with latex gloves are also one of the key drivers to augmenting the adoption of these gloves for surgical procedures.

What are the Neoprene (Polychloroprene) Surgical Glove Market drivers?

• Growing cancer prevalence is anticipated to increase the demand for neoprene (polychloroprene) surgical gloves

Furthermore, these gloves also offer a longer chemical breakthrough, further making them suitable for their application in surgeries where bone cement and cytotoxic agents are used. Bone cement is widely used in orthopedic and trauma surgeries for implant fixation purposes. Cytotoxic agents are used for the treatment of cancer; these are used in cancer to destroy cancer cells.

Thus, the growing prevalence of cancer disease and an increasing number of cancer, trauma, and orthopedic surgeries, among others, are projected to significantly drive the demand for neoprene (polychloroprene) surgical gloves during the coming years and add up to the market growth.

According to the data provided by the Centers for Disease Control and Prevention (CDC) in the United States,1,752,735 new cancer cases were reported in 2019, thereby significantly driving the demand for these gloves in the coming years. In addition, the growing investments by major market players in R&D and the increase in production capacity coupled with new product launches are some of the additional factors showing the market potential for growth for the manufacturers during the forecast period.

• The rising incidence of latex allergies across the globe is fuelling the demand for neoprene surgical gloves

The rising incidence of latex allergy among healthcare workers is the major driver of synthetic surgical gloves, thereby supplementing the growth of the neoprene surgical gloves market as well. People across the globe are increasingly developing allergic reactions to certain proteins present in natural rubber latex that are used to make both medical and industrial gloves. The growing healthcare sector is projected to be the largest source of job creation in the coming years. The increasing global population is leading to a mushrooming demand for healthcare services worldwide.

Furthermore, the growing geriatric population in countries like the U.S., Japan, and China is also driving the demand for home healthcare solutions and services. Healthcare workers are, thus, at the highest risk of latex exposure. According to the American Latex Allergy Association, 8-17% of healthcare workers in the U.S. are sensitized to natural rubber latex. Thus, all these factors are collectively contributing to boosting the demand for these gloves, especially in developed economies.

Hospitals and clinics are expected to hold a noteworthy share in the global market because the majority of the surgeries are performed in hospitals as general super specialty or multi-specialty hospitals are equipped with the most advanced and latest instruments on account of higher funding capabilities. Ambulatory Surgical Centers are expected to grow substantially over the forecast period on account of the increasing ability of these centers to improve treatment quality along with the reduction of costs as more patients tend to visit them rather than go to hospitals owing to lower treatment costs.

Geographical outlook of the Neoprene (Polychloroprene) Surgical Glove Market:

• The North American region holds a noteworthy market share

North America is estimated to hold the major market share on account of the rising geriatric population in countries like the U.S. and Canada, along with the growing medical tourism industry in Mexico. The growing middle-class population in Mexico is leading to an increase in the prevalence of lifestyle-related chronic diseases in the country.

According to the World Health Organization (WHO), the country accounts for the most hospitalizations related to diabetes among the Organization for Economic Cooperation and Development’s (OECD) 35 countries. These factors are contributing to the escalating number of surgical procedures being performed in the country, which, in turn, is boosting the demand for synthetic surgical gloves in Mexico. Furthermore, rising healthcare expenditure and increasing government support for healthcare services are also contributing to the market growth in the region.

Key developments in the Neoprene (Polychloroprene) Surgical Glove Market:

• April 2024: Mölnlycke Health Care AB acquired P.G.F. Industry Solutions GmbH, a leading manufacturer of wound cleansing products to further solidify its position as a global leader in wound care. The strategic acquisition is expected to enhance the company's product portfolio and improve its ability to offer advanced wound care solutions. By leveraging the expertise of the newly acquired company, Mölnlycke intends to improve the outcomes for patients and meet the increasing need for wound management products.
• April 2024: Ansell signed a deal with Kimberly-Clark's Personal Protective Equipment unit for the acquisition in exchange for $640 million. The deal enhanced Ansell's product portfolio, especially in scientific and industrial markets, with two globally recognized brands - Kimtech and KleenGuard, which KCPPE. 

Neoprene (Polychloroprene) Surgical Glove Market Scope:

Report Metric	Details
Market Size Value in 2025	US$460.300 million
Market Size Value in 2030	US$598.712 million
Growth Rate	CAGR of 5.00%
Study Period	2020 to 2030
Historical Data	2020 to 2023
Base Year	2024
Forecast Period	2025 – 2030
Forecast Unit (Value)	USD Million
Segments Covered	End-User Geography
Companies Covered	Cardinal Health Ansell Limited Medline Industries, Inc. Top Glove Corporation Bhd Sempermed
Regions Covered	North America, South America, Europe, Middle East and Africa, Asia Pacific
Customization Scope	Free report customization with purchase

 

The Neoprene (Polychloroprene) Surgical Glove Market is analyzed into the following segments:

• By End-User
  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Others
• By Geography
  • North America
    • USA
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Spain
  • Others
    • Middle East and Africa
    • Saudi Arabia
    • Israel
    • Others
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Indonesia
    • Thailand
    • Taiwan
    • Others

---

1. INTRODUCTION

1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Market Segmentation

1.5. Currency

1.6. Assumptions

1.7. Base and Forecast Years Timeline

1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY  

2.1. Research Design

2.2. Research Processes

3. EXECUTIVE SUMMARY

3.1. Key Findings

4. MARKET DYNAMICS

4.1. Market Drivers

4.2. Market Restraints

4.3. Porter’s Five Forces Analysis

4.3.1. Bargaining Power of Suppliers

4.3.2. Bargaining Power of Buyers

4.3.3. Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis

4.5. Analyst View

5. NEOPRENE (POLYCHLOROPRENE) SURGICAL GLOVE MARKET BY END-USER 

5.1. Introduction

5.2. Hospitals and Clinics

5.2.1. Market Opportunities and Trends

5.2.2. Growth Prospects

5.2.3. Geographic Lucrativeness

5.3. Ambulatory Surgery Centers

5.3.1. Market Opportunities and Trends

5.3.2. Growth Prospects

5.3.3. Geographic Lucrativeness

5.4. Others 

5.4.1. Market Opportunities and Trends

5.4.2. Growth Prospects

5.4.3. Geographic Lucrativeness

6. NEOPRENE (POLYCHLOROPRENE) SURGICAL GLOVE MARKET BY GEOGRAPHY

6.1. Introduction

6.2. North America

6.2.1. By End-User

6.2.2. By Country

6.2.2.1. USA

6.2.2.1.1. Market Opportunities and Trends

6.2.2.1.2. Growth Prospects

6.2.2.2. Canada

6.2.2.2.1. Market Opportunities and Trends

6.2.2.2.2. Growth Prospects

6.2.2.3. Mexico

6.2.2.3.1. Market Opportunities and Trends

6.2.2.3.2. Growth Prospects

6.3. South America

6.3.1. By End-User

6.3.2. By Country 

6.3.2.1. Brazil

6.3.2.1.1. Market Opportunities and Trends

6.3.2.1.2. Growth Prospects

6.3.2.2. Argentina

6.3.2.2.1. Market Opportunities and Trends

6.3.2.2.2. Growth Prospects

6.3.2.3. Others

6.3.2.3.1. Market Opportunities and Trends

6.3.2.3.2. Growth Prospects

6.4. Europe

6.4.1. By End-User

6.4.2. By Country

6.4.2.1. Germany

6.4.2.1.1. Market Opportunities and Trends

6.4.2.1.2. Growth Prospects

6.4.2.2. France

6.4.2.2.1. Market Opportunities and Trends

6.4.2.2.2. Growth Prospects

6.4.2.3. United Kingdom

6.4.2.3.1. Market Opportunities and Trends

6.4.2.3.2. Growth Prospects

6.4.2.4. Spain

6.4.2.4.1. Market Opportunities and Trends

6.4.2.4.2. Growth Prospects

6.4.2.5. Others

6.4.2.5.1. Market Opportunities and Trends

6.4.2.5.2. Growth Prospects

6.5. Middle East and Africa

6.5.1. By End-User

6.5.2. By Country

6.5.2.1. Saudi Arabia

6.5.2.1.1. Market Opportunities and Trends

6.5.2.1.2. Growth Prospects

6.5.2.2. Israel

6.5.2.2.1. Market Opportunities and Trends

6.5.2.2.2. Growth Prospects

6.5.2.3. Others

6.5.2.3.1. Market Opportunities and Trends

6.5.2.3.2. Growth Prospects

6.6. Asia Pacific

6.6.1. By End-User

6.6.2. By Country

6.6.2.1. China

6.6.2.1.1. Market Opportunities and Trends

6.6.2.1.2. Growth Prospects

6.6.2.2. Japan

6.6.2.2.1. Market Opportunities and Trends

6.6.2.2.2. Growth Prospects

6.6.2.3. South Korea

6.6.2.3.1. Market Opportunities and Trends

6.6.2.3.2. Growth Prospects

6.6.2.4. India

6.6.2.4.1. Market Opportunities and Trends

6.6.2.4.2. Growth Prospects

6.6.2.5. Indonesia

6.6.2.5.1. Market Opportunities and Trends

6.6.2.5.2. Growth Prospects

6.6.2.6. Thailand

6.6.2.6.1. Market Opportunities and Trends

6.6.2.6.2. Growth Prospects

6.6.2.7. Taiwan

6.6.2.7.1. Market Opportunities and Trends

6.6.2.7.2. Growth Prospects

6.6.2.8. Others

6.6.2.8.1. Market Opportunities and Trends

6.6.2.8.2. Growth Prospects

7. COMPETITIVE ENVIRONMENT AND ANALYSIS

7.1. Major Players and Strategy Analysis

7.2. Market Share Analysis

7.3. Mergers, Acquisitions, Agreements, and Collaborations

7.4. Competitive Dashboard

8. COMPANY PROFILES

8.1. Mölnlycke Health Care AB (A subsidiary of Investor AB)

8.2. Cardinal Health

8.3. Ansell Limited

8.4. Medline Industries, Inc.

8.5. Top Glove Corporation Bhd

8.6. Sempermed

8.7. DACH Schutzbekleidung GmbH & Co. KG

8.8. OWENS & MINOR

Mölnlycke Health Care AB (A subsidiary of Investor AB)

Cardinal Health

Ansell Limited

Medline Industries, Inc.

Top Glove Corporation Bhd

Sempermed

DACH Schutzbekleidung GmbH & Co. KG

OWENS & MINOR